Matches in Nanopublications for { ?s ?p "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838062.RAVu6PwWABnAfnbl7edPA9MuPpm3WtgDAof20NLPgqgHI130_provenance.
- assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP825332.RAR9hRWJ1zyDHbystgOnoWNEwZlFjFG5zOHcXF9HlovBg130_assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825332.RAR9hRWJ1zyDHbystgOnoWNEwZlFjFG5zOHcXF9HlovBg130_provenance.
- NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825333.RAXP4v6Ma1nRRnj7quIsQACejYWdMWylBEuWw4C55ci-k130_provenance.
- NP838045.RAiDmYDTf70YaWC2leXcV9J4mj23ErUEGxTuUhK1aICyg130_assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838045.RAiDmYDTf70YaWC2leXcV9J4mj23ErUEGxTuUhK1aICyg130_provenance.
- NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838050.RA0-Jn4h1oBjymWOl3U2OPtv2tZ4Qvb5q-Vn1fJVyVjUo130_provenance.
- NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_assertion description "[Ack1 Tyr284 phosphorylation is prognostic of progression of prostate cancer and inhibitors of Ack1 activity could be novel therapeutic agents to treat AIPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825334.RA-qDK8hTP8DJSZXGMXR3itecM-A28QkGD_zQpc8RnDRo130_provenance.